Inventiva (IVA) Non Operating Income (2020 - 2021)
Inventiva (IVA) posted quarterly Non Operating Income of -$735809.8 for Q2 2021, down 66703.13% year-over-year from N/an in Q2 2020, and down 142.51% quarter-over-quarter from $1.7 million in Q1 2021.
Inventiva (IVA) Non Operating Income (2020 - 2021) Analysis & Trends
Inventiva's Non Operating Income history runs 2 years deep, the most recent figure standing at -$735809.8 for Q2 2021.
- In Q2 2021, Non Operating Income fell 66703.13% year-over-year to -$735809.8; the TTM figure through Jun 2021 stood at -$3.7 million (changed N/A YoY), while the FY2025 annual figure was -$247.7 million, down 169.45% from the prior year.
- Non Operating Income for Q2 2021 stood at -$735809.8, down from $1.7 million in the prior quarter.
- The five-year high for Non Operating Income was $1.7 million in Q1 2021, with the low at -$4.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -735,809.85 |
| Mar 31, 2021 | 1.73 Mn |
| Dec 31, 2020 | -4.65 Mn |
| Jun 30, 2020 | -1,101.46 |
| Mar 31, 2020 | 7,727.57 |